A new UC San Francisco study sheds light on the diversity within the most common type of pediatric liver tumor and suggests a way forward for more precise chemotherapy treatment.... Read More >

Myriad Genetics said Friday that Japan's Ministry of Health, Labor, and Welfare has granted expanded coverage for the firm's BRACAnalysis test as a companion diagnostic to identify patients with early-stage... Read More >

German firm Oncgnostics said on Thursday that China's National Medical Products Administration approved its DNA methylation-based cervical cancer GynTect assay.... Read More >

Norwegian life sciences company Age Labs on Wednesday announced a partnership with Bay Area biotech BioAge Labs to harness data from a longitudinal Norwegian health study to develop new diagnostics and drugs.... Read More >

In the first half of 2022, among the four major business lines of the company, the infectious disease business income reached 3.207 billion CNY, a significant increase of 240.32% over the same period of last year. ... Read More >

Roche said on Wednesday that its Ventana PD-L1 test has received a CE label expansion for its Ventana PD-L1 SP263 test to determine non-small cell lung cancer patients' eligibility for Roche's immune checkpoint inhibitor Tecentriq (atezolizumab).... Read More >

CorDx said on Wednesday that it has received CE marking for a monkeypox virus antigen test. Read More >

Gongdong Medical recently released its 2022 semi-annual report, in which the company achieved operating revenue of CNY 799 million, an increase of 38.70% year-on-year; net profit attributable to shareholders of the listed company was CNY 211 million, an increase of 18.92% year-on... Read More >

The Wyss Institute and Harvard University said on Tuesday that they have licensed protein detection technology to Spear Bio. Read More >

Merck, known as MSD outside the United States and Canada, today announced that the U.S. FDA has granted Fast Track designation for Merck’s investigational anticoagulant therapy MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients with end-stage... Read More >